Methods for preventing and/or treating flavivirus infection are disclosed. The method comprises administering to a subject in need thereof a composition comprising: a) a dopamine D2 receptor antagonist in an amount effective for preventing and/or treating flavivirus infection

Disclosed is the use of a dopamine receptor D2 inhibitor medicament for treating depression improving cognition and/or treating other syndromes conditions or diseases for which anti-depressant agents are prescribed. The dopamine receptor D2 inhibitor medicament is formulated for administration in an administration cycle the administration cycle comprising: i. administering the D2 receptor inhibitor to elevate amounts of the D2 receptor's high affinity state inducing dopamine receptor supersensit...

Disclosed is a novel pharmaceutical composition for external application for increasing the permeation of prochlorperazine or a pharmaceutically acceptable salt thereof through the skin to allow prochlorperazine or the pharmaceutically acceptable salt thereof to exhibit its excellent pharmacological activity. Specifically disclosed is a novel pharmaceutical composition for external application, which contains prochlorperazine or a pharmaceutically acceptable salt thereof as an active ingredient ...

Disclosed is a novel pharmaceutical composition for external application for increasing the permeation of prochlorperazine or a pharmaceutically acceptable salt thereof through the skin to allow prochlorperazine or the pharmaceutically acceptable salt thereof to exhibit its excellent pharmacological activity. Specifically disclosed is a novel pharmaceutical composition for external application which contains prochlorperazine or a pharmaceutically acceptable salt thereof as an active ingredient a...

Disclosed is a blister pack containing medicinal tablets, formed of a metallic material, comprising a base part containing pockets for the tablets formed of a cold-formed foil comprising a metallic layer, over which a breachable-by-tablet metallic foil is laid, wherein the tablets comprise from 3 to 10 mg of prochlorperazine maleate, and wherein the tablets in the pack are protected from damage by water.

Disclosed is a novel pharmaceutical composition for external application for increasing the permeation of prochlorperazine or a pharmaceutically acceptable salt thereof through the skin to allow prochlorperazine or the pharmaceutically acceptable salt thereof to exhibit its excellent pharmacological activity. Specifically disclosed is a novel pharmaceutical composition for external application which contains prochlorperazine or a pharmaceutically acceptable salt thereof as an active ingredient a...

The present invention relates to the delivery of antipsychotics through an inhalation route. Specifically it relates to aerosols containing antipsychotics that are used in inhalation therapy. In a composition aspect of the present invention the aerosol comprises particles comprising at least 5 percent by weight of an antipsychotic. In a method aspect of the present invention an antipsychotic is delivered to a mammal through an inhalation route. The method comprises a) Heating a composition where...

Disclosed is a novel pharmaceutical composition for external application for increasing the permeation of prochlorperazine or a pharmaceutically acceptable salt thereof through the skin to allow prochlorperazine or the pharmaceutically acceptable salt thereof to exhibit its excellent pharmacological activity. Specifically disclosed is a novel pharmaceutical composition for external application which contains prochlorperazine or a pharmaceutically acceptable salt thereof as an active ingredient a...